Nyxoah NYXH Stock
$1.58
-0.628930%
Add to favorites
SECTOR
INDUSTRY
COUNTRY
Exchange
Market Cap
$158.12M
LOW - HIGH [24H]
$1.56
-
$1.59
VOLUME [24H]
$86.66K
P/E Ratio
0
Earnings per share
-$2.52
ISIN
BE0974358906
Nyxoah Price Chart
Nyxoah NYXH Financial and Trading Overview
| Nyxoah stock price | 1.58 USD |
| Previous Close | 1.59 USD |
| Open | 1.57 USD |
| Bid | 1.44 USD x 100 |
| Ask | 1.41 USD x 100 |
| Day's Range | 1.57 - 1.59 USD |
| 52 Week Range | 1.26 - 6.94 USD |
| Volume | 86.66K USD |
| Avg. Volume | 326.39K USD |
| Market Cap | 158.12M USD |
| Beta (5Y Monthly) | 0.947 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.52 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.98 USD |
NYXH Valuation Measures
| Enterprise Value | 121.32M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.5780299 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 7.2988534 |
| Price/Book (mrq) | 1.6473095 |
| Enterprise Value/Revenue | 5.6 |
| Enterprise Value/EBITDA | -1.466 |
Trading Information
Nyxoah Stock Price History
| Beta (5Y Monthly) | 0.947 |
| 52-Week Change | -76.76% |
| S&P500 52-Week Change | 19.50% |
| 52 Week High | 6.94 USD |
| 52 Week Low | 1.26 USD |
| 50-Day Moving Average | 1.62 USD |
| 200-Day Moving Average | 3.49 USD |
NYXH Share Statistics
| Avg. Volume (3 month) | 326.39K USD |
| Avg. Daily Volume (10-Days) | 139.23K USD |
| Shares Outstanding | 100.07M |
| Float | 58.04M |
| Short Ratio | 2.31 |
| % Held by Insiders | 33.77% |
| % Held by Institutions | 26.45% |
| Shares Short | 438.56K |
| Short % of Float | 0.50% |
| Short % of Shares Outstanding | 0.44% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -268.24% |
| Gross Margin | 60.18% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -36.86% |
| Return on Equity (ttm) | -122.68% |
Income Statement
| Revenue (ttm) | 21.66M USD |
| Revenue Per Share (ttm) | 0.49 USD |
| Quarterly Revenue Growth (yoy) | 472.79% |
| Gross Profit (ttm) | 13.04M USD |
| EBITDA | -82744000 USD |
| Net Income Avi to Common (ttm) | -96004000 USD |
| Diluted EPS (ttm) | -2.52 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 97.79M USD |
| Total Cash Per Share (mrq) | 0.98 USD |
| Total Debt (mrq) | 59.99M USD |
| Total Debt/Equity (mrq) | 72.18 USD |
| Current Ratio (mrq) | 2.384 |
| Book Value Per Share (mrq) | 0.9591397 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -71855000 USD |
| Levered Free Cash Flow (ttm) | -46059124 USD |
Profile of Nyxoah
| Country | United States |
| State | N/A |
| City | Mont-Saint-Guibert |
| Address | Rue Edouard Belin 12 |
| ZIP | 1435 |
| Phone | 32 1 045 90 75 |
| Website | https://www.nyxoah.com |
| Industry | Medical Instruments & Supplies |
| Sector(s) | Healthcare |
| Full Time Employees | 153 |
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Q&A For Nyxoah Stock
What is a current NYXH stock price?
Nyxoah NYXH stock price today per share is 1.58 USD.
How to purchase Nyxoah stock?
You can buy NYXH shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nyxoah?
The stock symbol or ticker of Nyxoah is NYXH.
Which industry does the Nyxoah company belong to?
The Nyxoah industry is Medical Instruments & Supplies.
How many shares does Nyxoah have in circulation?
The max supply of Nyxoah shares is 100.07M.
What is Nyxoah Price to Earnings Ratio (PE Ratio)?
Nyxoah PE Ratio is now.
What was Nyxoah earnings per share over the trailing 12 months (TTM)?
Nyxoah EPS is -2.52 USD over the trailing 12 months.
Which sector does the Nyxoah company belong to?
The Nyxoah sector is Healthcare.
Nyxoah NYXH included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26588.49 USD — |
+0.54
|
7.14B USD — | 26531.93 USD — | 26688.24 USD — | — - | 7.14B USD — |
|
US Tech Global Market Composite
NQGM
US
|
2362.13 USD — |
+0.33
|
— — | 2360.81 USD — | 2374.79 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1313.07 USD — |
+0.37
|
— — | 1299.17 USD — | 1316.86 USD — | — - | — — |
- {{ link.label }} {{link}}
